Eli Lily Prescribes a Healthy Dose of Revenue
Eli Lilly and Company (NYSE: LLY) reported its latest quarterly performance last week, showcasing an ongoing display of dominance. The pharmaceutical juggernaut surged ahead with a remarkable 5% increase in…